DUCTAL CARCINOMA IN SITU
Clinical trials for DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to zap pre-cancer breast cells before surgery
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012, which is injected directly into pre-cancerous breast tissue (DCIS or LCIS). The goal is to see if it is safe and can treat these abnormal cells before standard surgery. About 24 adults with a single lesion between 1 and 5 cm wil…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 17, 2026 00:42 UTC
-
New scanner could slash repeat breast cancer surgeries by half
Diagnosis Not yet recruitingThis study tests a special scanner that lets surgeons check if all cancer has been removed during breast-conserving surgery, right in the operating room. The goal is to see if this real-time check reduces the need for a second surgery. About 228 women with certain types of breast…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Hôpital du Valais • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
New scanner aims for sharper breast cancer pictures
Diagnosis Not yet recruitingThis study is testing a new type of MRI scanner to see if it can measure the size of a specific type of early breast cancer more accurately. Twelve patients scheduled for surgery will get both a standard MRI and the new scan. Researchers will compare the scan results to the actua…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: University of Aberdeen • Aim: Diagnosis
Last updated Apr 23, 2026 12:43 UTC